enGene Therapeutics Inc. (ENGN) stock
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
$2.41+0.13 (+5.70%)
Close on Nov 13, 2026Market cap $161.51MP/E –Yield 0.00%
enGene Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
enGene Therapeutics's enterprise value was -$120.54M on Nov 11, 2026, against $228.22M a year earlier. Over the last 4 years it ranged from -$138.63M to $347.50M, with a median of $38.58M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$120.54M | -141.4% |
| 2025 | Dec 31, 2025 | $291.32M | +136.6% |
| 2024 | Dec 31, 2024 | $123.14M | -13.2% |
| 2023 | Dec 29, 2023 | $141.81M | – |
| 2022 | Dec 30, 2022 | -$3.91M | – |
See a number that looks wrong?